188 related articles for article (PubMed ID: 34379341)
1. Acute and chronic effects of endocardial radiofrequency ablation of septal hypertrophy in HOCM.
Lawrenz T; Lawin D; Radke K; Stellbrink C
J Cardiovasc Electrophysiol; 2021 Oct; 32(10):2617-2624. PubMed ID: 34379341
[TBL] [Abstract][Full Text] [Related]
2. Ablation of hypertrophic septum using radiofrequency energy: an alternative for gradient reduction in patient with hypertrophic obstructive cardiomyopathy?
Riedlbauchová L; Janoušek J; Veselka J
J Invasive Cardiol; 2013 Jun; 25(6):E128-32. PubMed ID: 23735367
[TBL] [Abstract][Full Text] [Related]
3. Endocardial Radiofrequency Ablation vs. Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis.
Jiang T; Huang B; Huo S; Mageta LM; Guo J; Lv J; Lin L
Front Surg; 2022; 9():859205. PubMed ID: 35558385
[TBL] [Abstract][Full Text] [Related]
4. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
[TBL] [Abstract][Full Text] [Related]
5. From 100 to 0: Endocardial Radiofrequency Ablation of Septal Hypertrophy for Management of Hypertrophic Cardiomyopathy.
Peigh G; Wasserlauf J; Choudhury L; Knight BP; Kim S
JACC Case Rep; 2020 Jul; 2(8):1173-1177. PubMed ID: 34317442
[TBL] [Abstract][Full Text] [Related]
6. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound® technology to guide ablation.
Cooper RM; Shahzad A; Hasleton J; Digiovanni J; Hall MC; Todd DM; Modi S; Stables RH
Europace; 2016 Jan; 18(1):113-20. PubMed ID: 26541709
[TBL] [Abstract][Full Text] [Related]
8. Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months' follow-up in 19 patients.
Lawrenz T; Borchert B; Leuner C; Bartelsmeier M; Reinhardt J; Strunk-Mueller C; Meyer Zu Vilsendorf D; Schloesser M; Beer G; Lieder F; Stellbrink C; Kuhn H
J Am Coll Cardiol; 2011 Feb; 57(5):572-6. PubMed ID: 21272748
[TBL] [Abstract][Full Text] [Related]
9. Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy.
Lawrenz T; Kuhn H
Z Kardiol; 2004 Jun; 93(6):493-9. PubMed ID: 15252744
[TBL] [Abstract][Full Text] [Related]
10. Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.
Burghardt A; van Buuren F; Dimitriadis Z; Grübbel T; Seggewiss H; Scholtz S; Horstkotte D; Faber L
Clin Res Cardiol; 2018 Jun; 107(6):479-486. PubMed ID: 29453593
[TBL] [Abstract][Full Text] [Related]
11. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy.
Kuhn H; Gietzen FH; Leuner C; Schäfers M; Schober O; Strunk-Müller C; Obergassel L; Freick M; Gockel B; Lieder F; Raute-Kreinsen U
Z Kardiol; 2000; 89 Suppl 4():IV41-54. PubMed ID: 10810776
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy through non-left anterior descending septal perforators.
Imori Y; Takano H; Kitamura M; Aoyama R; Sangen H; Kenta O; Matsuda J; Kubota Y; Tokita Y; Yamamoto T; Asai K; Takayama M; Shimizu W
Heart Vessels; 2020 May; 35(5):647-654. PubMed ID: 31641886
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy.
Zhou M; Ta S; Hahn RT; Hsi DH; Leon MB; Hu R; Zhang J; Zuo L; Li J; Wang J; Wang B; Zhu X; Liu J; Han Y; Li X; Xu B; Zhang L; Hou L; Han C; Liu J; Liu L
JAMA Cardiol; 2022 May; 7(5):529-538. PubMed ID: 35353129
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].
Liu LW; Zuo L; Zhou MY; Li J; Zhou XD; He GB; Zhang J; Zhang JZ; Liu B; Yang J; Xu B
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):284-290. PubMed ID: 31060187
[No Abstract] [Full Text] [Related]
15. Selective Interventricular Septal Radiofrequency Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?
Liu Q; Qiu H; Jiang R; Tang X; Guo W; Zhou K; Chen Q; Sun Y; Yu L; Chen S; Zhang P; Sheng X; Zhu J; Lin J; Cheng H; Wang Y; Wang B; Yu C; Mao Y; Zhang J; Zhang Z; Zei PC; Fu G; Jiang C
Front Cardiovasc Med; 2021; 8():743044. PubMed ID: 34869646
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of radiofrequency ablation for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.
Yang H; Yang Y; Xue Y; Luo S
Clin Cardiol; 2020 May; 43(5):450-458. PubMed ID: 32034788
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency septal reduction in symptomatic hypertrophic obstructive cardiomyopathy.
Crossen K; Jones M; Erikson C
Heart Rhythm; 2016 Sep; 13(9):1885-90. PubMed ID: 27132152
[TBL] [Abstract][Full Text] [Related]
18. Predictors of long-term outcome after septal myectomy in symptomatic hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation and residual obstruction.
Zhu C; Tang B; Cui H; Wang S; Xiao M; Chen Z; Meng Y; Zhao S; Song Y; Yu Q; Wang S
J Card Surg; 2019 Jul; 34(7):533-540. PubMed ID: 31111576
[TBL] [Abstract][Full Text] [Related]
19. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience.
Kuhn H; Lawrenz T; Lieder F; Leuner C; Strunk-Mueller C; Obergassel L; Bartelsmeier M; Stellbrink C
Clin Res Cardiol; 2008 Apr; 97(4):234-43. PubMed ID: 18071624
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy.
Liu L; Li J; Zuo L; Zhang J; Zhou M; Xu B; Hahn RT; Leon MB; Hsi DH; Ge J; Zhou X; Zhang J; Ge S; Xiong L
J Am Coll Cardiol; 2018 Oct; 72(16):1898-1909. PubMed ID: 30309466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
